Data from: Metabolic changes associated with two endocrine abnormalities in dogs: elevated fructosamine and low thyroxine

Metabolomics studies in canine endocrine abnormalities are sparse and
basic information on these abnormalities must be generated. This dataset
includes the 1H NMR metabolic profiling results of 151 dog serum samples.
The samples have been collected in an ethical way, being leftovers of
clinical diagnostic samples. The sample set includes 25 control samples
based on unremarkable routine clinical chemistry and hematology, 79
samples exhibiting high fructosamine which reflects poor glycemic control,
and 47 samples with low thyroxine, a metabolically important thyroid
hormone. The metabolite data and metadata were utilized in the study:
Ottka et al. Metabolic changes associated with two endocrine abnormalities
in dogs: elevated fructosamine and low thyroxine. The control group
results were utilized also in: Ottka et al. Serum NMR metabolomics
uncovers multiple metabolic changes in phenobarbital-treated dogs.